Improving retinal imaging for early detection of age-related macular degeneration
Official title: Visible-to-near-infrared spanning Optical Coherence Tomography for retinal imaging at the half-micron scale
Funded at New York University School of Medicine · NIH-11058892 · Data updated 2026-11-12
This study is looking at new ways to take pictures of the eye to spot early signs of age-related macular degeneration (AMD) so that people can get help before their vision gets worse.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | New York University School of Medicine NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project start | June 1, 2025 |
| Project end | May 31, 2030 |
| Funding year | 2025 |
| Award (this year) | $673,747 |
| NIH project number | 1R01EY036192-01A1 |
| Project ID | NIH-11058892 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are older adults at risk for age-related macular degeneration or those showing early signs of the disease.
✕Less likely to help
Patients with advanced stages of age-related macular degeneration or those who do not have any risk factors for the disease may not benefit from this research.
What this research studies
This research focuses on enhancing retinal imaging techniques to detect early signs of age-related macular degeneration (AMD) before significant vision loss occurs. By utilizing advanced Optical Coherence Tomography (OCT) technology, the study aims to identify high-risk biomarkers associated with AMD progression. The approach involves measuring macular pigments and retinal pigment epithelium melanosomes with unprecedented precision, which could lead to earlier intervention and treatment. Patients will be monitored for changes in their retinal health using this innovative imaging method.
Why it matters
Potential benefit: If successful, this research could lead to earlier diagnosis and treatment of age-related macular degeneration, potentially preserving vision for many patients.
How similar studies have gone: Previous research has shown promise in using advanced imaging techniques for retinal health assessment, indicating that this approach could yield significant insights.
Where this research is happening
-
New York University School of Medicine
New York, United States Active
Researchers
- Principal investigator: Srinivasan, Vivek Jay — New York University School of Medicine
- Study coordinator: Srinivasan, Vivek Jay
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.